Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-005307
Filing Date
2023-02-16
Accepted
2023-02-16 19:59:43
Documents
1
Period of Report
2023-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3301
  Complete submission text file 0000899243-23-005307.txt   4637
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Issuer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address
Park Jin Whan (Reporting) CIK: 0001953687 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41390 | Film No.: 23639987